1. Everolimus-based combination for the treatment of advanced gastroenteropancreatic neuroendocrine neoplasms (GEP-NENs): biological rationale and critical review of published data
    Omar Abdel-Rahman et al, 2015, Tumor Biology CrossRef
  2. Bevacizumab-based combination therapy for advanced gastroenteropancreatic neuroendocrine neoplasms (GEP-NENs): a systematic review of the literature
    Omar Abdel-Rahman et al, 2015, Journal of Cancer Research and Clinical Oncology CrossRef
  3. Distinct Expression Patterns of VEGFR 1-3 in Gastroenteropancreatic Neuroendocrine Neoplasms: Supporting Clinical Relevance, but not a Prognostic Factor
    Florian Bösch et al, 2020, Journal of Clinical Medicine CrossRef
  4. Immunotherapy of Pancreatic Cancer
    Ryan Stevenson et al, 2015, Cancer Immunology CrossRef
  5. Sequential treatment in disseminated well- and intermediate-differentiated pancreatic neuroendocrine tumors: Common sense or low rationale?
    Enrique Grande, 2016, World Journal of Clinical Oncology CrossRef
  6. New Therapy Options for Neuroendocrine Carcinoma of the Pancreas—The Emergent Substance GP-2250 and Gemcitabine Prove to Be Highly Effective without the Development of Secondary Resistances In Vitro and In Vivo
    Marie Buchholz et al, 2022, Cancers CrossRef
  7. Blocking SDF-1α/CXCR4 Downregulates PDGF-B and Inhibits Bone Marrow–Derived Pericyte Differentiation and Tumor Vascular Expansion in Ewing Tumors
    Randala Hamdan et al, 2014, Molecular Cancer Therapeutics CrossRef
  8. Strong Antitumor Activity of Bevacizumab and Aflibercept in Neuroendocrine Carcinomas: In-Depth Preclinical Study
    María Rodríguez-Remírez et al, 2020, Neuroendocrinology CrossRef
  9. Trifluridine/tipiracil increases survival rates in peritoneal dissemination mouse models of human colorectal and gastric cancer
    Norihiko Suzuki et al, 2017, Oncology Letters CrossRef
  10. Phase I dose escalation study of sorafenib plus S-1 for advanced solid tumors
    Hui-Jen Tsai et al, 2021, Scientific Reports CrossRef
  11. Vascular endothelial growth factor (VEGF) pathway and neuroendocrine neoplasms (NENs): prognostic and therapeutic considerations
    Omar Abdel-Rahman, 2014, Tumor Biology CrossRef